Vanessa Neuhaus

Hannover, NI, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Region-specific immune regulation determines differential response to JAK1 inhibition in Crohn's disease ex vivo.

Region-specific immune regulation determines differential response to JAK1 inhibition in Crohn's disease ex vivo.

Journal: Journal of Crohn's & colitis

Published: July 30, 2026

An explorable model of an adverse outcome pathway of cytokine release syndrome related to the administration of immunomodulatory biotherapeutics and cellular therapies.

An explorable model of an adverse outcome pathway of cytokine release syndrome related to the administration of immunomodulatory biotherapeutics and cellular therapies.

Journal: Frontiers in immunology

Published: March 28, 2025

Ex Vivo Modeling and Pharmacological Modulation of Tissue Immune Responses in Inflammatory Bowel Disease Using Precision-Cut Intestinal Slices.

Ex Vivo Modeling and Pharmacological Modulation of Tissue Immune Responses in Inflammatory Bowel Disease Using Precision-Cut Intestinal Slices.

Journal: European journal of immunology

Published: March 20, 2025

Using interactive platforms to encode, manage and explore immune-related adverse outcome pathways.

Using interactive platforms to encode, manage and explore immune-related adverse outcome pathways.

Journal: Journal of immunotoxicology

Published: December 10, 2024

An overview of immune safety avatar: mimicking the effects of immunomodulatory therapies on the immune system.

An overview of immune safety avatar: mimicking the effects of immunomodulatory therapies on the immune system.

Journal: Journal of immunotoxicology

Published: December 10, 2024

Type 2 responses determine skin rash during recombinant interleukin-2 therapy.

Type 2 responses determine skin rash during recombinant interleukin-2 therapy.

Journal: Journal of immunotoxicology

Published: December 10, 2024

Bridging therapy-induced phenotypes and genetic immune dysregulation to study interleukin-2-induced immunotoxicology.

Bridging therapy-induced phenotypes and genetic immune dysregulation to study interleukin-2-induced immunotoxicology.

Journal: Clinical immunology (Orlando, Fla.)

Published: April 08, 2024

IL-2-mediated hepatotoxicity: knowledge gap identification based on the irAOP concept.

IL-2-mediated hepatotoxicity: knowledge gap identification based on the irAOP concept.

Journal: Journal of immunotoxicology

Published: April 05, 2024

Interleukin-2-induced skin inflammation.

Interleukin-2-induced skin inflammation.

Journal: European journal of immunology

Published: May 30, 2023

A time-resolved meta-analysis of consensus gene expression profiles during human T-cell activation.

A time-resolved meta-analysis of consensus gene expression profiles during human T-cell activation.

Journal: Genome biology

Published: April 29, 2022

Assessment of the Cytotoxic and Immunomodulatory Effects of Substances in Human Precision-cut Lung Slices.

Assessment of the Cytotoxic and Immunomodulatory Effects of Substances in Human Precision-cut Lung Slices.

Journal: Journal of visualized experiments : JoVE

Published: May 29, 2018

Human Teratoma-Derived Hematopoiesis Is a Highly Polyclonal Process Supported by Human Umbilical Vein Endothelial Cells.

Human Teratoma-Derived Hematopoiesis Is a Highly Polyclonal Process Supported by Human Umbilical Vein Endothelial Cells.

Journal: Stem cell reports

Published: February 23, 2018

Showing 1-12 of 18

Last Updated: 09/26/2026